Tergenpumatucel-L

N/A

Report date: 2024/06/27 20:00:09

Base Information

Drug NameTergenpumatucel-L
Drug Alias NameHyperAcute Lung immunotherapyLung cancer vaccineHyperAcute Lung
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNewlink Genetics Co
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNewlink Genetics Co
Active IndicationsN/A
Inactive IndicationsCarcinoma, Non-Small-Cell Lung

Other Information

ATC CodeN/A
Related LinksN/A